{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T07:49:12Z","timestamp":1759564152293},"reference-count":24,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2008,6,1]],"date-time":"2008-06-01T00:00:00Z","timestamp":1212278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[2008,6]]},"DOI":"10.4065\/83.6.701","type":"journal-article","created":{"date-parts":[[2009,1,23]],"date-time":"2009-01-23T20:31:26Z","timestamp":1232742686000},"page":"701-707","source":"Crossref","is-referenced-by-count":6,"title":["Human Papillomavirus and Vaccination"],"prefix":"10.4065","volume":"83","author":[{"given":"Christine M.","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.4065\/83.6.701_bib1","author":"National Cancer Institute, US National Institutes of Health"},{"key":"10.4065\/83.6.701_bib2","author":"US Food and Drug Administration"},{"key":"10.4065\/83.6.701_bib3","author":"American Cancer Society"},{"issue":"1","key":"10.4065\/83.6.701_bib4","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/canjclin.57.1.7","article-title":"American Cancer Society guideline for human papillomavirus (HPV) vaccine use to prevent cervical cancer and its precursors","volume":"57","author":"Saslow","year":"2007","journal-title":"CA Cancer J Clin"},{"key":"10.4065\/83.6.701_bib5","author":"Pagliusi"},{"issue":"RR-2","key":"10.4065\/83.6.701_bib6","first-page":"1","article-title":"Quadrivalent human papillomavirus vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"56","author":"Markowitz","year":"2007","journal-title":"MMWR Recomm Rep"},{"issue":"7","key":"10.4065\/83.6.701_bib7","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1056\/NEJM199802123380703","article-title":"Natural history of cervicovaginal papillomavirus infection in young women","volume":"338","author":"Ho","year":"1998","journal-title":"N Engl J Med"},{"issue":"19","key":"10.4065\/83.6.701_bib8","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1056\/NEJMoa065497","article-title":"Case-control study of human papillomavirus and oropharyngeal cancer","volume":"356","author":"D'Souza","year":"2007","journal-title":"N Engl J Med"},{"issue":"8","key":"10.4065\/83.6.701_bib9","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1097\/01.olq.0000204545.89516.0a","article-title":"Human papillomavirus infection among sexually active young women in the United States: implications for developing a vaccination strategy","volume":"33","author":"Manhart","year":"2006","journal-title":"Sex Transm Dis"},{"issue":"8","key":"10.4065\/83.6.701_bib10","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1001\/jama.297.8.813","article-title":"Prevalence of HPV infection among females in the United States","volume":"297","author":"Dunne","year":"2007","journal-title":"JAMA"},{"issue":"25","key":"10.4065\/83.6.701_bib11","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1056\/NEJMoa053284","article-title":"Condom use and the risk of genital human papillomavirus infection in young women","volume":"354","author":"Winer","year":"2006","journal-title":"N Engl J Med"},{"issue":"21","key":"10.4065\/83.6.701_bib12","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1056\/NEJMoa020586","article-title":"A controlled trial of a human papillomavirus type 16 vaccine","volume":"347","author":"Koutsky","year":"2002","journal-title":"N Engl J Med"},{"issue":"1","key":"10.4065\/83.6.701_bib13","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/01.AOG.0000192397.41191.fb","article-title":"Efficacy of human papillomavirus-16 vaccine to prevent cervical intraepithelial neoplasia: a randomized controlled trial","volume":"107","author":"Mao","year":"2006","journal-title":"Obstet Gynecol"},{"issue":"5","key":"10.4065\/83.6.701_bib14","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S1470-2045(05)70101-7","article-title":"Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial","volume":"6","author":"Villa","year":"2005","journal-title":"Lancet"},{"issue":"19","key":"10.4065\/83.6.701_bib15","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1056\/NEJMoa061760","article-title":"Quadrivalent vaccine against the human papillomavirus to prevent anogenital diseases","volume":"356","author":"Garland","year":"2007","journal-title":"N Engl J Med"},{"issue":"19","key":"10.4065\/83.6.701_bib16","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1056\/NEJMoa061741","article-title":"Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions","volume":"356","author":"The FUTURE II Study Group","year":"2007","journal-title":"N Engl J Med"},{"issue":"27\u201328","key":"10.4065\/83.6.701_bib17","doi-asserted-by":"crossref","first-page":"5571","DOI":"10.1016\/j.vaccine.2006.04.068","article-title":"Immunologic responses following administration of a vaccine targeting human papillomavirus types 6, 11, 16, and 18","volume":"24","author":"Villa","year":"2006","journal-title":"Vaccine"},{"issue":"11","key":"10.4065\/83.6.701_bib18","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1038\/sj.bjc.6603469","article-title":"High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6\/11\/16\/18 L1 virus-like particle vaccine though 5 years of follow-up","volume":"95","author":"Villa","year":"2006","journal-title":"Br J Cancer"},{"key":"10.4065\/83.6.701_bib19","series-title":"Gardasil [human papillomavirus quadrivalent (types 6,11,16,18) vaccine, Recombinant] [package insert]","year":"2006"},{"key":"10.4065\/83.6.701_bib20","author":"American College of Obstetricians and Gynecologists"},{"key":"10.4065\/83.6.701_bib21","author":"National Conference of State Legislatures"},{"issue":"23","key":"10.4065\/83.6.701_bib22","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1056\/NEJMp068248","article-title":"The ethics and politics of compulsory HPV vaccination","volume":"355","author":"Colgrove","year":"2006","journal-title":"N Engl J Med"},{"issue":"9518","key":"10.4065\/83.6.701_bib23","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/S0140-6736(06)68439-0","article-title":"Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial","volume":"367","author":"Harper","year":"2006","journal-title":"Lancet"},{"issue":"9580","key":"10.4065\/83.6.701_bib24","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1016\/S0140-6736(07)60946-5","article-title":"Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial","volume":"369","author":"Paavaonen","year":"2007","journal-title":"Lancet"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619611608987?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619611608987?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,22]],"date-time":"2018-12-22T02:55:54Z","timestamp":1545447354000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025619611608987"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6]]},"references-count":24,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2008,6]]}},"alternative-id":["S0025619611608987"],"URL":"https:\/\/doi.org\/10.4065\/83.6.701","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[2008,6]]}}}